Mangiferin modulation of metabolism and metabolic syndrome
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The recent emergence of a worldwide epidemic of metabolic disorders, such as obesity and diabetes, demands effective strategy to develop nutraceuticals or pharmaceuticals to halt this trend. Natural products have long been and continue to be an attractive source of nutritional and pharmacological therapeutics. One such natural product is mangiferin (MGF), the predominant constituent of extracts of the mango plant Mangifera indica L. Reports on biological and pharmacological effects of MGF increased exponentially in recent years. MGF has documented antioxidant and anti‐inflammatory effects. Recent studies indicate that it modulates multiple biological processes involved in metabolism of carbohydrates and lipids. MGF has been shown to improve metabolic abnormalities and disorders in animal models and humans. This review focuses on the recently reported biological and pharmacological effects of MGF on metabolism and metabolic disorders. © 2016 BioFactors, 42(5):492–503, 2016
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pal, P. B., Sinha, K., & Sil, P. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056894 · Cited by 98
RetractedHeart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517 · cited 1×
“A recent structural comparison between about 10,000 Traditional Chinese Medicine components and about 8,000 modern drugs or candidates identified 908 agent pairs that are structurally similar and 327 agent pairs that are identical in structure [12,13], indicating an apparent high level of natural products or “natural…”
Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
The cellular and signaling networks linking the immune system and metabolism in disease
Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551 · cited 1×
“One of the theories holds that adipose expansion leads to formation of hypertrophic adipocytes that secreting chemoattractants and leukotriene B4 (LTB4), which in turn causes influx of immune cells to adipose tissue, initiating a cascade of inflammatory events [100].”
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Cited by
Wang, Z., Guo, S., Wang, J., Shen, Y., Zhang, J., & Wu, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-12160-6 · Cited by 92
Sadhukhan, P., Saha, S., Dutta, S., & Sil, P. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00638 · Cited by 81
“Mangiferin, a naturally occurring polyphenolic compound, exhibiting antioxidant, anti-inflammatory, anti-diabetic and anti-tumor effects, is one of the most potent bioactive xanthonoid molecules identified till date (Benard and Chi, 2015; Fomenko and Chi, 2016).”
BackgroundAdhesive nanoparticles with inflammation regulation for promoting skin flap regeneration
Mao, X., Liu, L., Cheng, L., Cheng, R., Zhang, L., Deng, L., Sun, X., Zhang, Y., Sarmento, B., & Cui, W. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.031 · Cited by 45
Chen, M., Wang, Z., Zhou, W., Lu, C., Ji, T., Yang, W., Jin, Z., Tian, Y., Lei, W., Wu, S., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174236 · Cited by 40
Mangifera indica L. Leaves as a Potential Food Source of Phenolic Compounds with Biological Activity
Sferrazzo, G., Palmeri, R., Restuccia, C., Parafati, L., Siracusa, L., Spampinato, M., Carota, G., Distefano, A., Di Rosa, M., Tomasello, B., et al. (2022) · Antioxidants · doi:10.3390/antiox11071313 · Cited by 31
Guo, X., Cheng, M., Hu, P., Shi, Z., Chen, S., Liu, H., Shi, H., Xu, Z., Tian, X., & Huang, C. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03763 · Cited by 25
Pinneo, S., O'Mealy, C., Rosas Jr., M., Tsang, M., Liu, C., Kern, M., Hooshmand, S., & Hong, M. Y. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2021.0063 · Cited by 19
Xiang, G., Guo, S., Xing, N., Du, Q., Qin, J., Gao, H., Zhang, Y., & Wang, S. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500150 · Cited by 18
Noh, J.-W., Lee, H.-Y., & Lee, B.-C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315329 · Cited by 17
“protects pancreatic β-cells, and improves diabetes complications by controlling the crosstalk between lipid and carbohydrate metabolisms [10,11].”
Background
Metadata
- Authors
- Fomenko, E. V., & Chi, Y.
- Venue
- BioFactors
- Publisher
- Wiley
- Published
- 2016-08-18
- Volume
- 42
- Issue
- 5
- Pages
- 492-503
- ISSN
- 0951-6433 (ISSN-L)
- 1872-8081
- OpenAlex
- W2511071291
- Cited by
- 68
- References
- 42
- FWCI
- 11.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.